Rhytids in the Glabellar Region
Conditions
Brief summary
The purpose of this study is to evaluate the ability of the Serene RF System to effectively improve the appearance of dynamic glabellar lines and sustain the effect for a minimum of 3 months.
Interventions
DEVICESerene RF System
The Serene RF System provides percutaneous delivery of radiofrequency (RF) energy to a targeted nerve.
Sponsors
Serene Medical Inc
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes
Inclusion criteria
1. Glabellar lines rating of at least two per the Merz Scale 2. Written informed consent 3. Understands and accepts the following obligations during the follow-up period (minimum of three months and up to one year) 4. available for the 3 day phone call and present for each follow-up visit; 5. receive NO other facial procedures in the upper face for a minimum of three months and up to one year after the RF procedure; 6. make NO changes to the eyebrows for a minimum of three months after the RF procedure.
Exclusion criteria
1. Injection of botulinum toxin to the upper face within the previous four months 2. Use of fillers in the upper face within the previous twelve months 3. Use of prescription treatments (e.g., Renova, Retin-A, micro-dermabrasion, chemical peels) on the upper face, in the area between the eyebrows where frown lines occur, within the previous four weeks or plans to use these treatments during the study 4. Facial or skin conditions that could interfere with treatment or confound results (e.g., signs or symptoms of eyebrow or eyelid ptosis, facial nerve palsy, scarring, infection) 5. Implanted pacemaker or automatic implantable cardioverter/defibrillator 6. History of keloid formation 7. Known bleeding disorder 8. Use of thrombolytics, anticoagulants, aspirin or non-steroidal anti-inflammatory drugs within seven days prior to study treatment Is receiving systemic corticosteroids or anabolic steroids (standard doses of inhaled or nasal corticosteroids are acceptable) 9. History of chronic or recurrent infection, or compromised immune system 10. Known lidocaine hypersensitivity 11. Enrollment in another research study 12. Pregnant, or plans to get pregnant during the follow-up period 13. Any other condition or circumstance that might either pose a risk, in the investigator's opinion, to the subject or interfere with the ability to acquire satisfactory clinical data throughout the follow-up period
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The reduction of glabellar lines | 3 months | The reduction of glabellar lines will be assessed by a panel of 3 independent reviewers with expertise in dermatology and/or plastic surgery of the change in glabellar lines measured from baseline to 3, 6, 9 and 12 months post procedure. Photographs will be presented in a random order and the reviewers will be blinded to whether the photograph is baseline or a follow up. Effectiveness of the procedure is defined by a ≥ 1 point improvement in score (i.e., numerical decrease) on the Mertz Aesthetics Scale™ (Merz Scale) for dynamic glabellar lines. At each time point the severity of the glabellar lines is assessed on a 5 point scale. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Incidence and severity of adverse events | 3 months | — |
| The reduction of glabellar lines | 12 months | The reduction of glabellar lines will be assessed by a panel of 3 independent reviewers with expertise in dermatology and/or plastic surgery of the change in glabellar lines measured from baseline to 3, 6, 9 and 12 months post procedure. Photographs will be presented in a random order and the reviewers will be blinded to whether the photograph is baseline or a follow up. Effectiveness of the procedure is defined by a ≥ 1 point improvement in score (i.e., numerical decrease) on the Mertz Aesthetics Scale™ (Merz Scale) for dynamic glabellar lines. At each time point the severity of the glabellar lines is assessed on a 5 point scale. |
| Subject satisfaction | 12 months | Subject satisfaction will be assessed by a survey given every 3 months. This survey asks the subject questions to rate on a scale of 0-4 with 0 representing very dissatisfied and 4 representing very satisfied. |
Countries
United States
Outcome results
None listed